Global Next-Generation Ultrasound Systems Market will reach $ 14,974.5 million by 2031, growing by 7.7% annually over 2021-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 85 tables and 92 figures, this 175-page report “Global Next-Ge...
North America next-generation ultrasound systems market is projected to grow by 7.2% annually in the forecast period and reach $5,727.8 million by 2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 26 tables and 56 figures, this 113-page ...
Europe next-generation ultrasound systems market was valued at $1,541.9 million in 2021 and will grow by 6.1% annually over 2021-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 36 tables and 60 figures, this 120-page report “Europe N...
Asia Pacific next-generation ultrasound systems market will grow by 9.8% annually with a total addressable market cap of $ 31,245.5 million over 2022-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 33 tables and 59 figures, this 120-pa...
Global nutrigenomics market will reach $2,691.3 million by 2031, growing by 15.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 86 tables and 91 figures, this 178-page report “Global Nutrigenomics ...
North America nutrigenomics market is projected to grow by 14.8% annually in the forecast period and reach $986.4 million by 2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 25 tables and 55 figures, this 115-page report ...
Europe nutrigenomics market was valued at $187.2 million in 2021 and will grow by 14.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 35 tables and 59 figures, this 122-page report “Europe Nutrigen...
Asia Pacific nutrigenomics market will grow by 16.9% annually with a total addressable market cap of $4,313.0 million over 2022-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 32 tables and 58 figures, this 121-page repo...
Global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 80 tables and 89 figures, this 196-page report “Global ...
North America ophthalmic drug delivery system market is projected to grow by 6.1% annually in the forecast period and reach $12,809.8 million by 2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population. Highlighted with 20 tables and 53 figures, this 1...
